KRAS and colorectal carcinoma: This observation may contradict the findings in another study that revealed the induction of glycolysis, the accumulation of lactic acid and the sensitivity to glycolytic inhibition in KRAS-mutated CRC cells, whereas BRAF-mutated CRC cells remained resistant towards the alterations of glucose supply or metabolic inhibitors [39].